Manufacturer
Jubilant Radiopharma
Pharmaceutical manufacturer based in India
Indian manufacturerIndia
- Products listed
- 8
- Molecules
- 7
- Therapy areas
- 1
Jubilant Radiopharma is a pharmaceutical manufacturer based in India. MedsAcross lists 8 of its products across 7 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- India
- Indian manufacturer
- Yes
- Also listed as
- Jubilant DraxImage Inc., dba Jubilant Radiopharma
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Jubilant Radiopharma products through licensed channels, with the documents your regulator needs.
Contrast media and diagnostics
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Drax Exametazime 0.5 mg powder for injectionIntravenous | Technetium tc-99m exametazime | US FDA | Available on request |
| Fludeoxyglucose f-18 300 mCi/mL injectionIntravenousGeneric name | Fludeoxyglucose f-18 | US FDA | Available on request |
Other products
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Betiatide 1 mg powder for injectionIntravenousGeneric name | Betiatide | US FDA | Available on request |
| Draximage Dtpa 20 mg powder for injectionInhalation, intravenous | Pentetic acid | US FDA | Available on request |
| Hicon 1000 mCi/mL oral solutionOral | Sodium iodide i-131 | US FDA | Available on request |
| Medronic acid 25 mg powder for injectionIntravenousGeneric name | Medronic acid | US FDA | Available on request |
| Ruby-fill 100 mCi injectionIntravenous | Rubidium chloride rb-82 | US FDA | Available on request |
| Sodium Iodide I 131 Diagnostic 100 mCi capsuleOral | Sodium iodide i-131 | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Jubilant Radiopharma
Send a request for any of these products. We confirm the licensed source, documents and lead time.